Our weekly list of news, reports, and information about home health and hospice care. Learn about new studies, trends, CMS regulations and more.
Complications from heart failure are among the most common causes for a readmission. Research shows that about 20% of heart failure patients return to the hospital within a month after discharge. That's why home health provider Amedisys has launched a program to help heart failure patients better manage their health and well-being so they are less likely to visit the ED unnecessarily. The program, which began last year, encourages patients to keep a daily record of their blood pressure, weight and other symptoms associated with the disease, like shortness of breath.
Not one or two standing ovations were enough for Brookdale Community College faculty, staff and board of trustees to express their joy over the new home-grown president of the 14,000-student school. David Stout earned three rounds of applause as he was named the seventh president in Brookdale's history The board of trustees selected Stout after a nationwide search that started last fall. A pool of 48 candidates applied and was narrowed using a screening committee that included college trustees, faculty members, administrators, students, alumni and a community member.
North Carolina lawmakers are pushing ahead with a new bill to set payment and coverage parity standards for telehealth, while also requiring patient consent before any treatment. The bill, HB 967, follows up on legislation passed last year that called for a State Department of Health and Human Services study, along with research into whether the state should sign onto the Psychology Interjurisdictional Compact (PSYPACT).
Centers for Medicare and Medicaid Services Administrator Seema Verma today unveiled the agency's enhanced drug pricing dashboards, a key piece in efforts to control the cost of medications. The Medicare and Medicaid drug price dashboards for the first time include year-over-year comparisons on drug pricing. Past policies capping drug manufacturer penalties have encouraged higher list prices for drugs, Verma said during a forum on America's Health Future by The Washington Post, reiterating statements by Health and Human Services Secretary Alex Azar.